GobyMeds Tirzepatide Review: Cost & Honest Verdict (2026)

GobyMeds: $299/month appears on its funnel page, consistent with roster data describing aggressively low pricing. Beyond that single number, though, this review found very little else to verify — the site is a Salesforce-hosted landing page rather than a full telehealth platform site. Every fact here comes from the company's own published program.

What GobyMeds is

GobyMeds is a telehealth provider, offering compounded semaglutide. The site itself is hosted on a Salesforce funnel page (my.gobymeds.com) rather than a dedicated company website — an unusual setup that limits how much program detail is available to review.

What GobyMeds costs

$299/month appears on the site, all doses. This is described as an aggressively low monthly rate for this category.

Very limited public disclosure

Worth flagging directly: limited public information exists about GobyMeds' program details beyond the headline price — no named compounding pharmacy, no accreditation badge, and no published state list were found.

The brand-vs-compounded question

GobyMeds dispenses compounded tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

GobyMeds' real strength: an aggressively low headline price. The trade-offs are significant: this review found very limited public information about the program beyond that price, no named compounding pharmacy, no visible accreditation, and no published state list — and the site itself is a minimal funnel page rather than a full platform. As with any GLP-1 program, and especially one this thin on public disclosure, ask directly about the compounding pharmacy, accreditation, and state coverage before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

GobyMeds' confirmed low price is the only clear positive this review could find — the program otherwise sits behind a minimal funnel page with none of the transparency signals (named pharmacy, accreditation, state list) this site typically looks for. Ask directly before committing anywhere. For providers with fuller public disclosure at a similarly low price, compare it against BiltRx or Fresh Day Meds. See our best tirzepatide providers ranking for the full field.